Activation of Src in human breast tumor cell lines: Elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530

Oncogene

Volumn 18, Issue 5, 1999, Pages 1227-1237

  Egan, Cay ^a   Pang, Andrew ^a   Durda, Denise ^a   Cheng, Heung Chin ^a,c   Wang, Jerry H ^a,b   Fujita, Donald J ^a,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Breast cancer; Phosphotyrosyl phosphatase; Src kinase

Indexed keywords

PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; TYROSINE; VANADIC ACID;

ARTICLE; BREAST TUMOR; CARBOXY TERMINAL SEQUENCE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; ONCOGENE SRC; PRIORITY JOURNAL; TUMOR CELL LINE;

BREAST NEOPLASMS; CDC25 PHOSPHATASE; CELL CYCLE PROTEINS; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PEPTIDE FRAGMENTS; PHOSPHOPEPTIDES; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTORS, CELL SURFACE; SHP1 PROTEIN TYROSINE PHOSPHATASE; SRC-FAMILY KINASES; SUBSTRATE SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0033521886     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202233     Document Type: Article

References (46)

1. Berger MS, Locher GW, Saurer S, Gullick WJ, Waterfield MD, Groner B and Hynes NE. (1988). Cancer Res., 48, 1238-1243.
2. Bjorge JD, Bellagamba C, Cheng HC, Tanakab A, Wang JH and Fujita DJ. (1995). J Br. Cancer, 270, 24222-24228.
3. Cartwright CA, Eckhart W, Simon S and Kaplan PL. (1987). Cell, 49, 83-91.
4. Cartwright CA, Kamps MP, Meisler AI, Pipas JM and Eckhart W. (1989). J. Clin. Invest., 83, 2025-2033.
5. Cartwright CA, Meisler AI and Eckhart W. (1990). Proc. Natl. Acad. Sci. USA, 87, 558-562.
6. Charbonneau H and Tonks NK. (1992). Ann. Rev. Cell Biol., 8, 463-493.
7. den Hertog J, Pals CE, Peppelenbosch MP, Tertoolen LG, de Laat SW and Kruijer W. (1993). EMBO J., 12, 3789-3798.
8. Elson A and Leder P. (1995). J Br. Cancer, 270, 26116-26122.
9. Galaktionov K, Lee AK, Eckstein J, Draetta G, Meckler J, Loda M and Beach D. (1995). Science, 269, 1575-1577.
10. Guy CT, Muthuswamy SK, Cardiff RD, Soriano P and Muller WJ. (1994). Genes & Dev., 8, 23-32.
11. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD and Muller WJ. (1992). Proc. Natl. Acad. Sci. USA, 89, 10578-10582.
12. Jacobs C and Rubsamen H. (1983). Cancer Res., 43, 1696-1702.
13. Janes PW, Daly RJ, deFazio A and Sutherland RL. (1994). Oncogene, 9, 3601-3608.
14. Jove R, Kornbluth S and Hanafusa H. (1987). Cell, 50, 937-943.
15. Kmiecik TE and Shalloway D. (1987). Cell 49, 65-73.
16. Kraus MH, Fedi P, Starks V, Muraro R and Aaronson SA. (1993). Proc. Natl. Acad. Sci. USA, 90, 2900-2904.
17. Kraus MH, Popescu NC, Amsbaugh SC and King CR. (1987). EMBO J., 6, 605-610.
18. Litwin CM, Cheng HC and Wang JH. (1991). J. Biol. Chem, 266, 2557-2566.
19. Luttrell DK, Lee A, Lansing TJ, Crosby RM, Jung KD, Willard D, Luther M, Rodriguez M, Berman J and Gilmer TM. (1994). Proc. Natl. Acad. Sci. USA, 91, 83-87.
20. Luttrell DK, Luttrell LM and Parsons SJ. (1988). Mol. Cell. Biol., 8, 497-501.
21. Maa MC, Leu TH, McCarley DJ, Schatzman RC and Parsons SJ. (1995). Proc. Natl. Acad. Sci. USA, 92, 6981-6985.
22. Muthuswamy SK and Muller WJ. (1995). Oncogene, 11, 271-279.
23. Muthuswamy SK, Siegel PM, Dankort DL, Webster MA and Muller WJ. (1994). Mol. Cell. Biol., 14, 735-743.
24. O'Connor TJ, Bjorge JD, Cheng HC, Wang JH and Fujita DJ. (1995). Cell Growth Differ., 6, 123-130.
25. Ottenhoff-Kalff AE, Rijksen G, van Beurden EA, Hennipman A, Michels AA and Staal GE. (1992). Cancer Res., 52, 4773-4778.
26. Oude Weernink PA, Ottenhoff-Kalff AE, Vendrig MP, van Beurden EA, Staal GE and Rijksen G. (1994). FEBS Letts, 352, 296-300.
27. Pallen CJ. (1993). Sem. Cell Biol., 4, 403-408.
28. Peng ZY and Cartwright CA. (1995). Oncogene, 11, 1955-1962.
29. Roche S, Koegl M, Barone MV, Roussel MF and Courtneidge SA. (1995). Mol. Cell. Biol., 15, 1102-1109.
30. Rosen N, Bolen JB, Schwartz AM, Cohen P, DeSeau V and Israel MA. (1986). J Br. Cancer, 261, 13754-13759.
31. Shen SH, Bastien L, Posner BI and Chretien P. (1991). Nature, 352, 736-739.
32. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL. (1987). Science, 235, 177-182.
33. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press MF. (1989). Science, 244, 707-712.
34. Somani A-K, Bignon JS, Mills GB, Siminovitch KA and Branch DR. (1997). J Br. Cancer, 272, 21113-21119.
35. Songyang Z, Carraway KL, Eck MJ, Harrison SC, Feldman RA, Mohammadi M, Schlessinger J, Hubbard SR, Smith DP, Eng C, Lorenzo MJ, Ponder BAJ, Mayer BJ and Cantley LC. (1995). Nature, 373, 536-539.
36. Stover DR, Becker M, Liebetanz J and Lydon NB. (1995). J Br. Cancer, 270, 15591-15597.
37. Talamonti MS, Roh MS, Curley SA and Gallick GE. (1993). J. Clin. Invest., 91, 53-60.
38. Tanaka A, Salem M, Eckroade RJ and Fujita DJ. (1990). Oncogene Res., 5, 305-322.
39. Tomic S, Greiser U, Lammers R, Kharitonenkov A, Imyanitov, E, Ullrich A and Bohmer FD. (1995). J. Br. Cancer, 270, 21277-21284.
40. Uckun FM, Tuel-Ahlgren L, Waddick KG, Jun X, Jin J, Myers DE, Rowley RB, Burkhardt AL and Bolen JB. (1996). J. Br. Cancer, 271, 6389-6397.
41. Varley JM, Swallow JE, Brammar WJ, Whittaker JL and Walker RA. (1987). Oncogene, 1, 423-430.
42. Webster MA, Cardiff RD and Muller WJ. (1995). Proc. Natl. Acad. Sci. USA, 92, 7849-7853.
43. Wilson LK, Luttrell DK, Parsons JT and Parsons SJ. (1989). Mol. Cell. Biol., 9, 1536-1544.
44. Yuan ZM, Kharbanda S and Kufe D. (1995). Biochemistry 34, 1058-1063.
45. Zhai YF, Beittenmiller H, Wang B, Gould MN, Oakley C, Esselman WJ and Welsch CW. (1993). Cancer Res., 53, (Suppl): 2272-2278.
46. Zheng XM, Wang Y and Pallen CJ. (1992). Nature, 359, 336-339.